Indianapolis, IN, United States of America

Angelika Regina Kraft

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angelika Regina Kraft. Retrieved from https://idiyas.com/inventor/angelika-regina-kraft

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Angelika Regina Kraft: Innovator in Synthetic Polysaccharide Antigens

Introduction

Angelika Regina Kraft is a notable inventor based in Indianapolis, IN (US). She has made significant contributions to the field of immunology through her innovative work on synthetic polysaccharide antigens. Her research focuses on developing solutions for inflammatory pathologies, showcasing her commitment to advancing medical science.

Latest Patents

Angelika holds 1 patent for her invention titled "Synthetic polysaccharide antigens for immunological intervention in disease." This patent provides synthetic polysaccharide antigens (SPAs) that possess either anti-inflammatory or inflammatory immunomodulatory properties, depending on their structure. The invention includes compositions comprising these SPAs and methods for using them to prevent or treat diseases that are susceptible to treatment with inflammatory immunomodulators.

Career Highlights

Angelika is currently employed at Eli Lilly and Company, where she continues to apply her expertise in immunology. Her work at this prestigious company allows her to collaborate with other talented professionals in the field, further enhancing her contributions to medical research.

Collaborations

Some of her notable coworkers include Larry C Blaszczak and John Astor Cleveland, Jr. Their collaboration fosters a dynamic environment for innovation and research, leading to advancements in therapeutic solutions.

Conclusion

Angelika Regina Kraft's work in synthetic polysaccharide antigens exemplifies her dedication to improving health outcomes through innovative research. Her contributions to immunology are paving the way for new treatments and interventions in inflammatory diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…